Eli Lilly Ends Coronavirus Antibody Treatment Trial, Other Studies Go On
The trial studied the efficacy of bamlanivimab and remdesivir on hospitalized COVID-19 patients - the same therapies given to President Trump. But researchers say people showed no marked improvement.
Read more on NPR
Monday, 26 October 2020
Eli Lilly Ends Coronavirus Antibody Treatment Trial, Other Studies Go On
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment
Nothing happens without a Reason
Make Something out of it.